Functional footprinting of regulatory DNA

An integrated encyclopedia of DNA elements in the human genome

The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072 · see citing works

Systematic Localization of Common Disease-Associated Variation in Regulatory DNA

Maurano, M. T., Humbert, R., Rynes, E., Thurman, R. E., Haugen, E., Wang, H., Reynolds, A. P., Sandstrom, R., Qu, H., Brody, J., et al. (2012) · Science · doi:10.1126/science.1222794 · Cited by 3,716 · see citing works

Genome editing with engineered zinc finger nucleases

Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S., & Gregory, P. D. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2842 · Cited by 2,285 · see citing works

A TALE nuclease architecture for efficient genome editing

Miller, J. C., Tan, S., Qiao, G., Barlow, K. A., Wang, J., Xia, D. F., Meng, X., Paschon, D. E., Leung, E., Hinkley, S. J., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1755 · Cited by 2,098 · see citing works

An improved zinc-finger nuclease architecture for highly specific genome editing

Miller, J. C., Holmes, M. C., Wang, J., Guschin, D. Y., Lee, Y.-L., Rupniewski, I., Beausejour, C. M., Waite, A. J., Wang, N. S., Kim, K. A., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1319 · Cited by 1,051 · see citing works

Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL

Shivdasani, R. A., Mayer, E. L., & Orkin, S. H. (1995) · Nature · doi:10.1038/373432a0 · Cited by 938 · see citing works

An expansive human regulatory lexicon encoded in transcription factor footprints

Neph, S. J., Vierstra, J. D., Stergachis, A. B., Reynolds, A. P., Haugen, E., Vernot, B., Thurman, R. E., John, S., Sandstrom, R. S., Johnson, A., et al. (2012) · Nature · doi:10.1038/nature11212 · Cited by 746 · see citing works

An Erythroid Enhancer of <i>BCL11A</i> Subject to Genetic Variation Determines Fetal Hemoglobin Level

Bauer, D. E., Kamran, S. C., Lessard, S., Xu, J., Fujiwara, Y., Lin, C., Shao, Z., Canver, M. C., Smith, E. C., Pinello, L., et al. (2013) · Science · doi:10.1126/science.1242088 · Cited by 653 · see citing works

DNA-Binding Specificities of the GATA Transcription Factor Family

Ko, L. J., & Engel, J. D. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.4011-4022.1993 · Cited by 575 · see citing works

Genome Engineering with Targetable Nucleases

Carroll, D. (2014) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060713-035418 · Cited by 541 · see citing works

A Rapid and General Assay for Monitoring Endogenous Gene Modification

Guschin, D. Y., Waite, A. J., Katibah, G. E., Miller, J. C., Holmes, M. C., & Rebar, E. J. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-753-2_15 · Cited by 500 · see citing works

Saturation editing of genomic regions by multiplex homology-directed repair

Findlay, G. M., Boyle, E. A., Hause, R. J., Klein, J. C., & Shendure, J. (2014) · Nature · doi:10.1038/nature13695 · Cited by 362 · see citing works

Proof of principle for transfusion of in vitro–generated red blood cells

Giarratana, M., Rouard, H., Dumont, A., Kiger, L., Safeukui, I., Pennec, P. L., François, S., Trugnan, G., Peyrard, T., Marie, T., et al. (2011) · Blood · doi:10.1182/blood-2011-06-362038 · Cited by 343 · see citing works

Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genomePreprint

DeKelver, R. C., Choi, V. M., Moehle, E. A., Paschon, D. E., Hockemeyer, D. F., Meijsing, S. H., Sancak, Y., Cui, X., Steine, E. J., Miller, J. C., et al. (2010) · Genome Research · doi:10.1101/gr.106773.110 · Cited by 310 · see citing works

Transient cold shock enhances zinc-finger nuclease–mediated gene disruption

Doyon, Y., Choi, V. M., Xia, D. F., Vo, T. D., Gregory, P. D., & Holmes, M. C. (2010) · Nature Methods · doi:10.1038/nmeth.1456 · Cited by 137 · see citing works

Update on fetal hemoglobin gene regulation in hemoglobinopathies

Bauer, D. E., & Orkin, S. H. (2010) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e3283420fd0 · Cited by 107 · see citing works

Genome‐Scale Mapping of DNase I Hypersensitivity

John, S., Sabo, P. J., Canfield, T. K., Lee, K., Vong, S., Weaver, M., Wang, H., Vierstra, J. D., Reynolds, A. P., Thurman, R. E., et al. (2013) · Current Protocols in Molecular Biology · doi:10.1002/0471142727.mb2127s103 · Cited by 92 · see citing works

Immunochemical estimation of haemoglobin types in red blood cells by FACS analysis

Thorpe, S. J., Thein, S. L., Sampietro, M., Craig, J. E., Mahon, B. P., & Huehns, E. R. (1994) · British Journal of Haematology · doi:10.1111/j.1365-2141.1994.tb04881.x · Cited by 89 · see citing works

Transcriptional profiling of cells sorted by RNA abundance

Klemm, S. L., Semrau, S., Wiebrands, K., Mooijman, D., Faddah, D. A., Jaenisch, R., & van Oudenaarden, A. (2014) · Nature Methods · doi:10.1038/nmeth.2910 · Cited by 36 · see citing works

Epigenetic Modifications and Chromosome Conformations of the Beta Globin Locus throughout Development

Chang, K., Fang, X., Wang, H., Huang, A., Cao, H., Yang, Y., Bonig, H. B., Stamatoyannopoulos, J. A., & Papayannopoulou, T. (2012) · Stem Cell Reviews and Reports · doi:10.1007/s12015-012-9355-x · Cited by 19 · see citing works

Developmental Silencing of Human ζ-Globin Gene Expression Is Mediated by the Transcriptional Repressor RREB1

Chen, R.-L., Chou, Y., Lan, Y., Huang, T.-S., & Shen, C. ‐. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.049130 · Cited by 18 · see citing works

Women, Genre and Circumstance: Essays in Memory of Elizabeth Fallaize ed. by by Margaret Atack, et al. (review)

Collado, M. (2013) · Women in French studies · doi:10.1353/wfs.2013.0014 · Cited by 1 · see citing works

The next generation of CRISPR–Cas technologies and applications

Pickar-Oliver, A., & Gersbach, C. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0131-5 · Cited by 1,459 · see citing works

The epigenetic landscape of T cell exhaustion

Sen, D. R., Kaminski, J., Barnitz, R. A., Kurachi, M., Gerdemann, U., Yates, K. B., Tsao, H.-W., Godec, J., LaFleur, M. W., Brown, F. D., et al. (2016) · Science · doi:10.1126/science.aae0491 · Cited by 986 · see citing works

Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity

Richter, M. F., Zhao, K. T., Eton, E., Lapinaite, A., Newby, G. A., Thuronyi, B. W., Wilson, C., Koblan, L. W., Zeng, J., Bauer, D. E., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0453-z · Cited by 1,020 · see citing works

Genome-editing Technologies for Gene and Cell Therapy

Maeder, M. L., & Gersbach, C. A. (2016) · Molecular Therapy · doi:10.1038/mt.2016.10 · Cited by 722 · see citing works

Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition

Kleinstiver, B. P., Prew, M. S., Tsai, S. Q., Nguyen, N. T., Topkar, V. V., Zheng, Z., & Joung, J. K. (2015) · Nature Biotechnology · doi:10.1038/nbt.3404 · Cited by 611 · see citing works

Inheritable silencing of endogenous genes by hit-and-run targeted epigenetic editing

Amabile, A., Migliara, A., Capasso, P., Biffi, M., Cittaro, D., Naldini, L., & Lombardo, A. (2016) · Cell · doi:10.1016/j.cell.2016.09.006 · Cited by 516 · see citing works

Highly efficient therapeutic gene editing of human hematopoietic stem cells

Wu, Y., Zeng, J., Roscoe, B. P., Liu, P., Yao, Q., Lazzarotto, C. R., Clement, K., Cole, M. A., Luk, K., Baricordi, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0401-y · Cited by 515 · see citing works

Promoter of lncRNA Gene PVT1 Is a Tumor-Suppressor DNA Boundary Element

Cho, S. W., Xu, J., Sun, R., Mumbach, M. R., Carter, A. C., Chen, Y. G., Yost, K. E., Kim, J., He, J., Nevins, S. A., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.068 · Cited by 459 · see citing works

CRISPR–Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome

Klann, T. S., Black, J. B., Chellappan, M., Safi, A., Song, L., Hilton, I. B., Crawford, G. E., Reddy, T. E., & Gersbach, C. A. (2017) · Nature Biotechnology · doi:10.1038/nbt.3853 · Cited by 447 · see citing works

Cornerstones of CRISPR–Cas in drug discovery and therapy

Fellmann, C., Gowen, B. G., Lin, P., Doudna, J. A., & Corn, J. E. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.238 · Cited by 442 · see citing works

Towards a comprehensive catalogue of validated and target-linked human enhancers

Gasperini, M., Tome, J. M., & Shendure, J. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-019-0209-0 · Cited by 396 · see citing works

Transcription factor–DNA binding: beyond binding site motifs

Inukai, S., Kock, K. H., & Bulyk, M. L. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.02.007 · Cited by 387 · see citing works

Making sense of GWAS: using epigenomics and genome engineering to understand the functional relevance of SNPs in non-coding regions of the human genome

Tak, Y. G., & Farnham, P. (2015) · Epigenetics & Chromatin · doi:10.1186/s13072-015-0050-4 · Cited by 342 · see citing works

Index and biological spectrum of human DNase I hypersensitive sites

Meuleman, W., Muratov, A., Rynes, E., Halow, J., Lee, K., Bates, D., Diegel, M., Dunn, D., Neri, F., Teodosiadis, A., et al. (2020) · Nature · doi:10.1038/s41586-020-2559-3 · Cited by 331 · see citing works

Therapeutic base editing of human hematopoietic stem cells

Zeng, J., Wu, Y., Ren, C., Bonanno, J., Shen, A. H., Shea, D. N., Gehrke, J. M., Clement, K., Luk, K., Yao, Q., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0790-y · Cited by 277 · see citing works

High-throughput mapping of regulatory DNA

Rajagopal, N., Srinivasan, S., Kooshesh, K., Guo, Y., Edwards, M. D., Banerjee, B., Syed, T., Emons, B. J. M., Gifford, D. K., & Sherwood, R. I. (2016) · Nature Biotechnology · doi:10.1038/nbt.3468 · Cited by 238 · see citing works

Lessons from Domestication: Targeting Cis-Regulatory Elements for Crop Improvement

Swinnen, G., Goossens, A., & Pauwels, L. (2016) · Trends in Plant Science · doi:10.1016/j.tplants.2016.01.014 · Cited by 224 · see citing works

Molecular basis of β thalassemia and potential therapeutic targets

Thein, S. L. (2017) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2017.06.001 · Cited by 208 · see citing works

Targeted gene addition in human CD34+ hematopoietic cells for correction of X-linked chronic granulomatous disease

De Ravin, S. S., Reik, A., Liu, P.-Q., Li, L., Wu, X., Su, L., Raley, C., Theobald, N., Choi, U., Song, A. H., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3513 · Cited by 195 · see citing works

Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus

Antoniani, C., Meneghini, V., Lattanzi, A., Felix, T., Romano, O., Magrin, E., Weber, L., Pavani, G., El Hoss, S., Kurita, R., et al. (2018) · Blood · doi:10.1182/blood-2017-10-811505 · Cited by 194 · see citing works

Genetic treatment of a molecular disorder: gene therapy approaches to sickle cell disease

Hoban, M. D., Orkin, S. H., & Bauer, D. E. (2016) · Blood · doi:10.1182/blood-2015-09-618587 · Cited by 194 · see citing works

Genome-scale high-resolution mapping of activating and repressive nucleotides in regulatory regions

Ernst, J., Melnikov, A., Zhang, X., Wang, L., Rogov, P., Mikkelsen, T. S., & Kellis, M. (2016) · Nature Biotechnology · doi:10.1038/nbt.3678 · Cited by 162 · see citing works

Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β ^A(T87Q) - <i>Globin</i> Gene

Negre, O., Eggimann, A.-V., Beuzard, Y., Ribeil, J.-A., Bourget, P., Borwornpinyo, S., Hongeng, S., Hacein-Bey, S., Cavazzana, M., Leboulch, P., et al. (2016) · Human Gene Therapy · doi:10.1089/hum.2016.007 · Cited by 159 · see citing works

Long-Term Engraftment and Fetal Globin Induction upon BCL11A Gene Editing in Bone-Marrow-Derived CD34 + Hematopoietic Stem and Progenitor Cells

Chang, K.-H., Smith, S. E., Sullivan, T., Chen, K., Zhou, Q., West, J. A., Liu, M., Liu, Y., Vieira, B. F., Sun, C., et al. (2017) · Molecular Therapy - Methods &amp; Clinical Development · doi:10.1016/j.omtm.2016.12.009 · Cited by 155 · see citing works

Sickle Cell Anemia and Its Phenotypes

Williams, T. N., & Thein, S. L. (2018) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-083117-021320 · Cited by 151 · see citing works

Current Progress in Therapeutic Gene Editing for Monogenic Diseases

Prakash, V., Moore, M., & Yáñez‐Muñoz, R. J. (2016) · Molecular Therapy · doi:10.1038/mt.2016.5 · Cited by 135 · see citing works

Diversifying the structure of zinc finger nucleases for high-precision genome editing

Paschon, D. E., Lussier, S. J., Wangzor, T., Xia, D. F., Li, P. W., Hinkley, S. J., Scarlott, N. A., Lam, S. C., Waite, A. J., Truong, L. N., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08867-x · Cited by 128 · see citing works

Gene Therapy for β-Hemoglobinopathies

Cavazzana, M., Antoniani, C., & Miccio, A. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.024 · Cited by 128 · see citing works

Epigenome editing technologies for discovery and medicine

McCutcheon, S. R., Rohm, D., Iglesias, N., & Gersbach, C. A. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02320-1 · Cited by 122 · see citing works

Emerging genetic therapy for sickle cell disease

Orkin, S. H., & Bauer, D. E. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-041817-125507 · Cited by 119 · see citing works

Wake-up Sleepy Gene: Reactivating Fetal Globin for β-Hemoglobinopathies

Wienert, B., Martyn, G. E., Funnell, A. P. W., Quinlan, K. G. R., & Crossley, M. (2018) · Trends in Genetics · doi:10.1016/j.tig.2018.09.004 · Cited by 115 · see citing works

Disruption of the BCL11A Erythroid Enhancer Reactivates Fetal Hemoglobin in Erythroid Cells of Patients with β-Thalassemia Major

Psatha, N., Reik, A., Phelps, S. R., Zhou, Y., Dalas, D., Yannaki, E., Levasseur, D. N., Urnov, F. D., Holmes, M. C., & Papayannopoulou, T. (2018) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2018.08.003 · Cited by 115 · see citing works

Recent progress in understanding and manipulating haemoglobin switching for the haemoglobinopathies

Vinjamur, D. S., Bauer, D. E., & Orkin, S. H. (2018) · British Journal of Haematology · doi:10.1111/bjh.15038 · Cited by 114 · see citing works

Therapeutically relevant engraftment of a CRISPR-Cas9–edited HSC-enriched population with HbF reactivation in nonhuman primates

Humbert, O., Radtke, S., Samuelson, C., Carrillo, R. R., Perez, A. M., Reddy, S. S., Lux, C. T., Pattabhi, S., Schefter, L. E., Nègre, O., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw3768 · Cited by 110 · see citing works

Enhanced Cas12a editing in mammalian cells and zebrafish

Liu, P., Luk, K., Shin, M., Idrizi, F., Kwok, S. F., Roscoe, B. P., Mintzer, E., Suresh, S., Morrison, K. S., Frazão, J. B., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz184 · Cited by 103 · see citing works

Precision genome engineering through adenine and cytosine base editing

Kim, J. (2018) · Nature Plants · doi:10.1038/s41477-018-0115-z · Cited by 108 · see citing works

Lentiviral and genome-editing strategies for the treatment of β-hemoglobinopathies

Magrin, E., Miccio, A., & Cavazzana, M. (2019) · Blood · doi:10.1182/blood.2019000949 · Cited by 97 · see citing works

Pathophysiology and treatment of patients with beta-thalassemia – an update

Fibach, E., & Rachmilewitz, E. A. (2017) · F1000Research · doi:10.12688/f1000research.12688.1 · Cited by 91 · see citing works

Cell and Gene Therapy for the Beta-Thalassemias: Advances and Prospects

Mansilla-Soto, J., Riviere, I., Boulad, F., & Sadelain, M. (2016) · Human Gene Therapy · doi:10.1089/hum.2016.037 · Cited by 83 · see citing works

A natural regulatory mutation in the proximal promoter elevates fetal globin expression by creating a de novo GATA1 site

Martyn, G. E., Wienert, B., Kurita, R., Nakamura, Y., Quinlan, K. G. R., & Crossley, M. (2019) · Blood · doi:10.1182/blood-2018-07-863951 · Cited by 75 · see citing works

Towards a new era in medicine: therapeutic genome editing

Porteus, M. H. (2015) · Genome Biology · doi:10.1186/s13059-015-0859-y · Cited by 69 · see citing works

Targeted deletion of BCL11A gene by CRISPR-Cas9 system for fetal hemoglobin reactivation: A promising approach for gene therapy of beta thalassemia disease

Khosravi, M. A., Abbasalipour, M., Concordet, J., Berg, J. V., Zeinali, S., Arashkia, A., Azadmanesh, K., Buch, T., & Karimipoor, M. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.04.042 · Cited by 71 · see citing works

Genome Editing B.C. (Before CRISPR): Lasting Lessons from the “Old Testament”

Urnov, F. D. (2018) · The CRISPR Journal · doi:10.1089/crispr.2018.29007.fyu · Cited by 68 · see citing works

BCL11A enhancer–edited hematopoietic stem cells persist in rhesus monkeys without toxicity

Demirci, S., Zeng, J., Wu, Y., Uchida, N., Shen, A. H., Pellin, D., Gamer, J., Yapundich, M., Drysdale, C. M., Bonanno, J., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci140189 · Cited by 65 · see citing works

Regulation of the fetal hemoglobin silencing factor BCL11A

Basak, A., & Sankaran, V. G. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13024 · Cited by 63 · see citing works

Customizing the genome as therapy for the β-hemoglobinopathies.

Canver, M. C., & Orkin, S. H. (2016) · Blood · doi:10.1182/blood-2016-01-678128 · Cited by 61 · see citing works

A versatile platform for locus-scale genome rewriting and verification

Brosh, R., Laurent, J. M., Ordóñez, R., Huang, E., Hogan, M. S., Hitchcock, A. M., MITCHELL, L. A., Pinglay, S., Cadley, J. A., Luther, R. D., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2023952118 · Cited by 61 · see citing works

Enhancing gene editing specificity by attenuating DNA cleavage kinetics

Miller, J. C., Patil, D. P., Xia, D. F., Paine, C. B., Fauser, F., Richards, H. W., Shivak, D. A., Bendaña, Y. R., Hinkley, S. J., Scarlott, N. A., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0186-z · Cited by 62 · see citing works

Gene Therapy for Hemoglobinopathies

Cavazzana, M., & Mavilio, F. (2018) · Human Gene Therapy · doi:10.1089/hum.2018.122 · Cited by 60 · see citing works

Understanding Spatial Genome Organization: Methods and Insights

Ramani, V., Shendure, J., & Duan, Z. (2016) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2016.01.002 · Cited by 58 · see citing works

Precision medicine, genomics and drug discovery: Table 1.

Cardon, L. R., & Harris, T. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw246 · Cited by 57 · see citing works

CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells

Kim, E. J., Kang, K. H., & Ju, J. H. (2017) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2016.198 · Cited by 57 · see citing works

New therapeutic targets in transfusion-dependent and -independent thalassemia

Cappellini, M. D., & Motta, I. (2017) · Hematology · doi:10.1182/asheducation-2017.1.278 · Cited by 57 · see citing works

CRISPR-Based Tools in Immunity

Simeonov, D. R., & Marson, A. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042718-041522 · Cited by 56 · see citing works

Recent advances in high-throughput approaches to dissect enhancer function

Santiago‐Algarra, D., Dao, L. T. M., Pradel, L. C., España, A. P., & Spicuglia, S. (2017) · F1000Research · doi:10.12688/f1000research.11581.1 · Cited by 56 · see citing works

Gene Therapy Approaches to Hemoglobinopathies

Ferrari, G., Cavazzana, M., & Mavilio, F. (2017) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2017.06.010 · Cited by 56 · see citing works

Hematopoietic Stem Cell Gene-Addition/Editing Therapy in Sickle Cell Disease

Germino-Watnick, P., Hinds, M. A., Le, A., Chu, R., Liu, X., & Uchida, N. (2022) · Cells · doi:10.3390/cells11111843 · Cited by 38 · see citing works

Evolution of hemoglobin loci and their regulatory elements

Philipsen, S., & Hardison, R. C. (2018) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2017.08.001 · Cited by 51 · see citing works

Genetic modifiers of fetal haemoglobin in sickle cell disease

Menzel, S., & Thein, S. L. (2019) · Molecular Diagnosis &amp; Therapy · doi:10.1007/s40291-018-0370-8 · Cited by 50 · see citing works

CRISPR-SURF: discovering regulatory elements by deconvolution of CRISPR tiling screen data

Hsu, J. Y., Fulco, C. P., Cole, M. A., Canver, M. C., Pellin, D., Sher, F., Farouni, R., Clement, K., Guo, J. A., Biasco, L., et al. (2018) · Nature Methods · doi:10.1038/s41592-018-0225-6 · Cited by 50 · see citing works

Enhanced HbF reactivation by multiplex mutagenesis of thalassemic CD34+ cells in vitro and in vivo

Psatha, N., Georgakopoulou, A., Li, C., Nandakumar, V., Georgolopoulos, G., Acosta, R., Paschoudi, K., Nelson, J. S., Chee, D. R., Athanasiadou, A., et al. (2021) · Blood · doi:10.1182/blood.2020010020 · Cited by 48 · see citing works

A Nonhuman Primate Transplantation Model to Evaluate Hematopoietic Stem Cell Gene Editing Strategies for β-Hemoglobinopathies

Humbert, O., Peterson, C. W., Norgaard, Z. K., Radtke, S., & Kiem, H. (2017) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2017.11.005 · Cited by 43 · see citing works

Complex Relationships between Chromatin Accessibility, Sequence Divergence, and Gene Expression in Arabidopsis thaliana

Alexandre, C. M., Urton, J. R., Jean-Baptiste, K., Huddleston, J., Dorrity, M. W., Cuperus, J. T., Sullivan, A. M., Bemm, F., Jolić, D., Arsovski, A. A., et al. (2017) · Molecular Biology and Evolution · doi:10.1093/molbev/msx326 · Cited by 44 · see citing works

Dissection of the Fgf8 regulatory landscape by in vivo CRISPR-editing reveals extensive intra- and inter-enhancer redundancy

Hörnblad, A., Bastide, S., Langenfeld, K., Langa, F., & Spitz, F. (2021) · Nature Communications · doi:10.1038/s41467-020-20714-y · Cited by 44 · see citing works

Concise Review: Epigenetic Regulation of Hematopoiesis: Biological Insights and Therapeutic Applications

Antoniani, C., Romano, O., & Miccio, A. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.17-0192 · Cited by 43 · see citing works

Biophysically Motivated Regulatory Network Inference: Progress and Prospects

Äijö, T., & Bonneau, R. (2016) · Human Heredity · doi:10.1159/000446614 · Cited by 30 · see citing works

CRISPR-Cas Technology as a Revolutionary Genome Editing tool: Mechanisms and Biomedical Applications

Ebrahimi, S., Khosravi, M. A., Raz, A., Karimipoor, M., & Parvizi, P. (2023) · ̒Ulūm va funūn-i bastah/bandī · doi:10.61186/ibj.27.5.219 · Cited by 40 · see citing works

Genetic therapies for sickle cell disease

Esrick, E. B., & Bauer, D. E. (2018) · Seminars in Hematology · doi:10.1053/j.seminhematol.2018.04.014 · Cited by 37 · see citing works

Gene Therapy of the Hemoglobinopathies

Kunz, J. B., & Kulozik, A. E. (2020) · HemaSphere · doi:10.1097/hs9.0000000000000479 · Cited by 38 · see citing works

Application of CRISPR/Cas to Understand Cis- and Trans-Regulatory Elements in Plants

Wolter, F., & Puchta, H. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8657-6_2 · Cited by 35 · see citing works

Functional interrogation of non-coding DNA through CRISPR genome editing

Canver, M. C., Bauer, D. E., & Orkin, S. H. (2017) · Methods · doi:10.1016/j.ymeth.2017.03.008 · Cited by 34 · see citing works

Gene editing without ex vivo culture evades genotoxicity in human hematopoietic stem cells

Zeng, J., Nguyen, M. A., Liu, P., da Silva, L. F., Levesque, S., Lin, L. Y., Justus, D. G., Petri, K., Clement, K., Porter, S. N., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.11.001 · Cited by 33 · see citing works

DNase I hypersensitivity mapping, genomic footprinting, and transcription factor networks in plants

Sullivan, A. M., Bubb, K. L., Sandstrom, R. S., Stamatoyannopoulos, J. A., & Queitsch, C. (2015) · Current Plant Biology · doi:10.1016/j.cpb.2015.10.001 · Cited by 33 · see citing works

Small Genetic Circuits and MicroRNAs: Big Players in Polymerase II Transcriptional Control in Plants

Megraw, M. S., Cumbie, J. S., Ivanchenko, M. G., & Filichkin, S. A. (2016) · The Plant Cell · doi:10.1105/tpc.15.00852 · Cited by 33 · see citing works

Gene therapy and gene editing strategies for hemoglobinopathies

Lidonnici, M. R., & Ferrari, G. (2018) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2017.12.001 · Cited by 34 · see citing works

A genome editing primer for the hematologist

Hoban, M. D., & Bauer, D. E. (2016) · Blood · doi:10.1182/blood-2016-01-678151 · Cited by 32 · see citing works

Molecular Medicine: Found in Translation

Orkin, S. H. (2021) · Med · doi:10.1016/j.medj.2020.12.011 · Cited by 35 · see citing works

Orthogonal Cas9–Cas9 chimeras provide a versatile platform for genome editing

Bolukbasi, M. F., Liu, P., Luk, K., Kwok, S. F., Gupta, A., Amrani, N., Sontheimer, E. J., Zhu, L. J., & Wolfe, S. A. (2018) · Nature Communications · doi:10.1038/s41467-018-07310-x · Cited by 30 · see citing works

Genome Editing for β-Hemoglobinopathies: Advances and Challenges

Frati, G., & Miccio, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030482 · Cited by 31 · see citing works

CRISPR/Cas-based gene editing in therapeutic strategies for beta-thalassemia

Zeng, S., Lei, S.-Y., Qu, C., Wang, Y., Teng, S., & Huang, P. C. (2023) · Human Genetics · doi:10.1007/s00439-023-02610-9 · Cited by 31 · see citing works

Precision Editing as a Therapeutic Approach for β-Hemoglobinopathies

Paschoudi, K., Yannaki, E., & Psatha, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119527 · Cited by 30 · see citing works

Editing outside the body: Ex vivo gene-modification for β-hemoglobinopathy cellular therapy

Rosanwo, T. O., & Bauer, D. E. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.10.002 · Cited by 27 · see citing works

Promise of gene therapy to treat sickle cell disease

Romero, Z. G., DeWitt, M. A., & Walters, M. C. (2018) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2018.1536119 · Cited by 26 · see citing works

Gene editing of PKLR gene in human hematopoietic progenitors through 5’ and 3’ UTR modified TALEN mRNA

Bustamante, O. Q., Fañanas-Baquero, S., Orman, I., Torres-Ruiz, R., Duchateau, P. N., Poirot, L., Gouble, A., Bueren, J. A., & Segovia, J. C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0223775 · Cited by 26 · see citing works

Pathogenic BCL11A variants provide insights into the mechanisms of human fetal hemoglobin silencing

Shen, Y., Li, R., Teichert, K., Montbleau, K. E., Verboon, J. M., Voit, R. A., & Sankaran, V. G. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009835 · Cited by 24 · see citing works

Gene Therapy and Genome Editing

Boulad, F., Mansilla‐Soto, J., Cabriolu, A., Rivière, I., & Sadelain, M. (2018) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2017.11.007 · Cited by 24 · see citing works

CRISPRpic: fast and precise analysis for CRISPR-induced mutations via p refixed i ndex c ounting

Lee, H., Chang, H. Y., Cho, S. W., & Ji, H. P. (2020) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqaa012 · Cited by 22 · see citing works

Zinc finger nuclease-mediated gene editing in hematopoietic stem cells results in reactivation of fetal hemoglobin in sickle cell disease

Lessard, S., Rimmelé, P., Ling, H., Moran, K., Vieira, B. F., Lin, Y.-D., Rajani, G. M., Hong, V., Reik, A., Boismenu, R., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-74716-7 · Cited by 21 · see citing works

BCL11A +58/+55 enhancer-editing facilitates HSPC engraftment and HbF induction in rhesus macaques conditioned with a CD45 antibody-drug conjugate

Demirci, S., Zeng, J., Palchaudhuri, R., Wu, C., Abraham, D. M., Hayal, T. B., Essawi, K., Nguyen, M. A., Stasula, U., Chu, R., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.10.014 · Cited by 22 · see citing works

Parallel genetics of regulatory sequences using scalable genome editing in vivo

Froehlich, J. J., Uyar, B., Herzog, M., Theil, K., Glažar, P., Akalin, A., & Rajewsky, N. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108988 · Cited by 17 · see citing works

In Vivo Hematopoietic Stem Cell Genome Editing: Perspectives and Limitations

Psatha, N., Paschoudi, K., Παπαδοπούλου, Α., & Yannaki, E. (2022) · Genes · doi:10.3390/genes13122222 · Cited by 23 · see citing works

Advances in genome editing: the technology of choice for precise and efficient β-thalassemia treatment

Ali, G., Tariq, M. A., Shahid, K., Ahmad, F. J., & Akram, J. (2020) · Gene Therapy · doi:10.1038/s41434-020-0153-9 · Cited by 20 · see citing works

A tetramer of BCL11A is required for stable protein production and fetal hemoglobin silencing

Zheng, G., Yin, M., Mehta, S., Chu, I.-T., Wang, S., Alshaye, A., Drainville, K., Buyanbat, A., Bienfait, F., Tenglin, K., et al. (2024) · Science · doi:10.1126/science.adp3025 · Cited by 18 · see citing works

Application of ATAC-seq in tumor-specific T cell exhaustion

Chen, C., Liu, J., Chen, Y., Lin, A., Mou, W., Zhu, L., Yang, T., Cheng, Q., Zhang, J., & Luo, P. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00495-w · Cited by 19 · see citing works

Recent advances in globin research using genome‐wide association studies and gene editing

Orkin, S. H. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13001 · Cited by 17 · see citing works

An evolving understanding of multiple causal variants underlying genetic association signals

Long, E., Williams, J., Zhang, H., & Choi, J. (2025) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2025.01.018 · Cited by 16 · see citing works

Gene therapy for hemoglobin disorders - a mini-review

Malik, P. (2016) · Journal of Rare Diseases Research & Treatment · doi:10.29245/2572-9411/2016/2.1028 · Cited by 16 · see citing works

A CRISPR view of gene regulation

Banerjee, B., & Sherwood, R. I. (2017) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2016.12.016 · Cited by 16 · see citing works

The Fetal-to-Adult Hemoglobin Switch — Mechanism and Therapy

Orkin, S. H. (2025) · New England Journal of Medicine · doi:10.1056/nejmra2405260 · Cited by 16 · see citing works

The Scope for Thalassemia Gene Therapy by Disruption of Aberrant Regulatory Elements

Patsali, P., Mussolino, C., Ladas, P., Floga, A., Kolnagou, A., Christou, S., Sitarou, M., Antoniou, M. N., Cathomen, T., Lederer, C. W., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111959 · Cited by 13 · see citing works

Computational resources to define alleles and altered regulatory motifs at genomically edited candidate response elements

Ehmsen, K. T., Knuesel, M. T., Martinez, D. M., Asahina, M., Aridomi, H., & Yamamoto, K. R. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab700 · Cited by 2 · see citing works

High-throughput mapping of regulatory DNA

Rajagopal, N., Srinivasan, S., Kooshesh, K., Guo, Y., Edwards, M. D., Banerjee, B., Syed, T., Emons, B. J. M., Gifford, D. K., & Sherwood, R. I. (2016) · Nature Biotechnology · doi:10.1038/nbt.3468 · Cited by 238 · see citing works

Nucleotide-resolution mapping of regulatory elements via allelic readout of tiled base editing v1Preprint

Becerra, B., Wittibschlager, S., Patel, Z. M., Kutschat, A. P., Delano, J., Che, E., Tauber, A., Wu, T., Starrs, M., Horstmann, C. S., et al. (2026) · doi:10.17504/protocols.io.4r3l2d16qg1y/v1

Nucleotide-resolution mapping of regulatory elements via allelic readout of tiled base editing

Becerra, B., Wittibschlager, S., Patel, Z. M., Kutschat, A. P., Delano, J., Che, E., Tauber, A., Wu, T., Starrs, M. M., Horstmann, C. S., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-69918-8 · Cited by 1 · see citing works

High-resolution genome-wide functional dissection of transcriptional regulatory regions and nucleotides in human

Wang, X., He, L., Goggin, S. M., Saadat, A., Wang, L., Sinnott-Armstrong, N., Claussnitzer, M., & Kellis, M. (2018) · Nature Communications · doi:10.1038/s41467-018-07746-1 · Cited by 159 · see citing works